Keywords: APIs; active pharmaceutical ingredients; FDA; U.S. Food and Drug Administration; ADRs; adverse drug reactions; DDD; defined daily dose; PBT; persistent, bioaccumulative, toxic; SSRI; selective serotonin reuptake inhibitor; Active pharmaceutical ingredient